Die KAIROS GmbH - an IQVIA business - ist ein renommierter IT-Spezialist, der auf die Erfahrung aus über zwölf Jahren Entwicklung von IT-Systemlösungen für das Gesundheitswesen zurückgreift. Neben technologischem Spezialwissen in der Implementierung medizinischer Middleware-Plattformen verfügen wir über umfangreiches Know-how bei der IT-unterstützten Orchestrierung von Arbeitsabläufen via Workflow Engines.
Overview
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 18, 2021 | Kairos Minerals : 18/11/2021 – Kairos Secures $7.1m Option Underwriting Agreement | ASX ANNOUNCEMENT 18 November 2021 Kairos Secures $7.1m Option Underwriting Agreement Additional funding will underpin the next phase of exploration across highly prospective gold and lithium projects within Kairos' Pilbara Project Highlight... |
| Jun 19, 2018 | Pride Capital Partners finances KAIROS’ international growth and share-repurchase | Amsterdam/Düsseldorf/Bochum, June 18, 2018 KAIROS has attracted a mezzanine loan from Pride Capital Partners to finance its international growth strategy. KAIROS offers a unique combination of biobanking and clinical trial management softw... |
Reviews 0
FAQ about Kairos
What has the press written about Kairos?
Parsers VC has collected 3 articles mentioning Kairos, among them “Kairos Minerals : 18/11/2021 – Kairos Secures $7.1m Option Underwriting Agreement” (Nov 18, 2021) and “Pride Capital Partners finances KAIROS’ international growth and share-repurchase” (Jun 19, 2018).
Is Kairos still active?
Yes, Kairos is active; its latest activity on Parsers VC dates from Nov 18, 2021.